Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now later-stage tilt small index

Malocclusion: later-stage trial registry

4 of 7 indexed Malocclusion trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #2,497 of 28,707 conditions by registered trial count.

7 US clinical trials · 4 currently recruiting · #2,497 of 28,707 conditions by registered trial count

Malocclusion: 7 US clinical trials tracked, 4 recruiting.

Malocclusion is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is University of North Carolina, Chapel Hill, running 2 of these trials.

Enrollment posture brief

Registry condition malocclusion

OPEN 4 | RECR 57% | LATE 1 | EARLY 0 | RANK #2497 | SPON 2

Nearest open-share peer: Adverse Childhood Experiences (57% recruiting · 14 trials)

ACL Tear71.4%ACL57.1%Malocclusion (this)57%Acute Myelogenous Leukemia42.9%Acne Scars28.6%
Open-enrollment share among volume-matched conditions near Malocclusion

Malocclusion lists 4 open slots (57% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Malocclusion on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Malocclusion is recruiting above its size-band peers.

    4 of 7 indexed trials (57.1%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Malocclusion research.

    University of North Carolina, Chapel Hill accounts for 2 of 7 trials (28.6%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Most Malocclusion trials plan to enrol fewer than 100 people.

    Median target enrolment is 90 among the 7 trials that report a genuine target (sentinel values excluded). 5 of those (71.4%) plan for fewer than 100 participants.

  4. Malocclusion research is mostly interventional.

    6 interventional and 1 observational studies make up this index (85.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 41

Phase Distribution

PhaseTrial count
Phase 4 1

Named interventions

Most-linked intervention names on Malocclusion records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

AcceleDent Aura Device
1 trials
Clear Aligner Device
1 trials
Movement Enhancement Technique Device
1 trials
Self-ligating brackets Device
1 trials
Twin brackets Device
1 trials
.016" Device
1 trials
.014" Device
1 trials
Clear Aligners Device
1 trials

US sites by state

Facility locations filed on Malocclusion trials. A trial with sites in several states counts in each.

North Carolina 3 trials
California 2 trials
Texas 1 trials
New Jersey 1 trials
Kentucky 1 trials
Illinois 1 trials
Florida 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Malocclusion page

7 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Malocclusion condition card totals 7 registered trials; most-linked intervention AcceleDent Aura; top US site state North Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.